Pharsight

Patent Number	Company	Patent Title	Patent Expiry	Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8461333	VIIV HLTHCARE	Salts of prodrugs of piperazine and substituted piperidine antiviral agents	Feb, 2025 (2 years from now)
US7745625	VIIV HLTHCARE	Prodrugs of piperazine and substituted piperidine antiviral agents	Nov, 2027 (5 years from now)
CN101941990B	VIIV HLTHCARE	Piperazine And Prodrug Of Substituted Piperidine Antiviral Drug	Mar, 2025 (2 years from now)
CN1953985A	VIIV HLTHCARE	Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents	Mar, 2025 (2 years from now)
CN101941990A	VIIV HLTHCARE	Pyrazine Antiviral Drug And Prodrug Of Piperazine And Substituted	Mar, 2025 (2 years from now)
CN1953985B	VIIV HLTHCARE	Piperazine And Prodrug Of Substituted Piperidine Antiviral Drug	Mar, 2025 (2 years from now)
IN200605355P1	VIIV HLTHCARE	Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents	Mar, 2025 (2 years from now)
IN254948B	VIIV HLTHCARE	A Compound Of Formula I	Mar, 2025 (2 years from now)
EP1725569B1	VIIV HLTHCARE	Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents	Mar, 2025 (2 years from now)
EP1725569A1	VIIV HLTHCARE	Prodrugs Of Piperazine And Substituted Piperidine Antiviral Agents	Mar, 2025 (2 years from now)
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8168615	VIIV HLTHCARE	Prodrugs of piperazine and substituted piperidine antiviral agents	Feb, 2025 (2 years from now)

Drugs and Companies using FOSTEMSAVIR TROMETHAMINE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

Strength	Dosage	Availability
EQ 600MG BASE	TABLET, EXTENDED RELEASE;ORAL	Prescription

availability in other generic markets.

Click on the highlighted region to filter.